(15925675), J. H., (15925678), X. S., (15925681), A. E., (14963396), T. E. A., (15078600), J. M., (15051480), J. X., . . . (14971443), E. S. A. (2025). Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Chicago-čujuhus (17. p.)(15925675), Justin Hwang, et al. Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> Versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. 2025.
MLA-čujuhus (9. p.)(15925675), Justin Hwang, et al. Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> Versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. 2025.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.